5-oxo-6,11-dihydro-5H-indeno[1,2-c]isoquinoline-9-sulfonamide | 1035563-76-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 5-oxo-6,11-dihydro-5H-indeno[1,2-c]isoquinoline-9-sulfonamide
• 英文别名: 5-Oxo-6,11-dihydroindeno[1,2-c]isoquinoline-9-sulfonamide
• CAS: 1035563-76-8
• 化学式: C₁₆H₁₂N₂O₃S
• 分子量: 312.349
• InChiKey: SXJIYPAUMNZAQU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  22
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  97.6
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Isoquinoline derivatives and methods of use thereof
  申请人：Inotek Pharmaceuticals Corporation

  公开号：EP2033645A1

  公开（公告）日：2009-03-11

  The present invention relates to Isoquinoline Derivatives, compositions comprising an effective amount of a Isoquinoline Derivative and methods for treating or preventing an inflammatory disease, a reperfusion injury, an ischemic condition, renal failure, diabetes, a diabetic complication, a vascular disease other than a cardiovascular disease, cardiovascular disease, reoxygenation injury resulting from organ transplantation, Parkinson's disease, or cancer, comprising administering to an animal in need thereof an effective amount of a Isoquinoline Derivative.

  本发明涉及异喹啉衍生物、包含有效量异喹啉衍生物的组合物以及用于治疗或预防炎症性疾病、再灌注损伤、缺血性疾病、肾衰竭、糖尿病、糖尿病并发症、心血管疾病以外的血管疾病、心血管疾病、器官移植导致的再氧损伤、帕金森病或癌症的方法，包括向有需要的动物施用有效量的异喹啉衍生物。
• SUBSTITUTED INDENO [1,2-C]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
  申请人：Inotek Pharmaceuticals Corporation

  公开号：EP1420785B1

  公开（公告）日：2010-04-28